Cervical Cancer Diagnostic Tests Market: Increase in Prevalence of Cervical Cancer among Women to Drive Global Market

Wilmington, Delaware, United States, Transparency Market Research Inc. Cervical cancer is a medical condition in which cells present in the lining of the cervix gradually develop into pre-cancerous mass of cells that ultimately turn into cancerous tumors. Two key types of cervical cancers that are typically screened and diagnosed in women are adenocarcinoma and squamous cell carcinoma.

Read Report Overview – https://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html

According to the World Health Organization (WHO), cervical cancer is the second most commonly prevalent cancer and the third-largest cause of death in women, with 530,000 new cases discovered each year.

Human papillomavirus (HPV) infection is responsible for 99% of the cervical cancer cases. Increase in incidence of weakened immune system, rapid spread of human papillomavirus (HPV) infection among the female population, and long-term use of oral contraceptive pills are the primary factors boosting the growth of the global cervical cancer diagnostic tests market. Moreover, other lifestyle-related factors such as smoking, multiple sex partners, and certain family history of cervical cancer are anticipated to fuel the growth of the global cervical cancer diagnostic tests market in the near future.

However, lack of education regarding the prevalence of cervical cancer and reluctance of the female population to undergo cervical cancer prognosis are projected to hamper the growth of the global cervical cancer diagnostic tests market. Moreover, unfavorable taxation and dearth of favorable reimbursement policies in countries of Europe and Asia Pacific are anticipated to restrain the global cervical cancer diagnostic tests market.

Request Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=736

Request a sample to get extensive insights into the Cervical Cancer Diagnostic Tests Market

The increase in prevalence of cervical cancer among women propels the global cervical cancer diagnostics market. In 2018, an estimated 570,000 women were diagnosed with cervical cancer globally and about 311,000 women succumbed to the disease. According to the World Health Organization (WHO), over 270,000 women die every year due to cervical cancer.

Increase in awareness about cancer diagnosis in the early stages and rise in demand for diagnostic & advanced screening techniques drive the global market. Moreover, high adoption rate of preventive diagnostic techniques among the population, technological advancements, and patient safety are expected to propel the cervical cancer diagnostic tests market in Asia Pacific, Latin America, and Middle East & Africa during the forecast period.

Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=736

Pap Smear Test Segment to Dominate Global Cervical Cancer Diagnostic Tests Market

In terms of diagnostic test, the global cervical cancer diagnostic tests market has been classified into pap smear test, HPV test, colposcopy, biopsy and endocervical curettage, and other diagnostic tests. The pap smear test segment accounted for the largest market share in 2021, and the trend is likely to continue during the forecast period. This can be attributed to increase in the number of patients with high-risk HPV infection & cervical cancer across the globe and surge in incidence of teenage sex, along with low pricing of the test.

Patient Preference for Hospitals for Tests and Treatments to Drive Global Market

Based on end-user, the global cervical cancer diagnostic tests market has been divided into hospitals, specialty clinics, and others. The hospitals segment held key share of the global cervical cancer diagnostic tests market in 2021. The growth of the segment can be ascribed to the availability of multiple service options & devices and tie-ups with healthcare companies in order to enhance medical products and service offerings. Moreover, hospitals are the preferred choice of patients due to the availability of advanced equipment and better health care services.

The specialty clinics segment is projected to grow at a high CAGR, especially in developed countries, due to rise in cervical cancer cases and improvements in health care infrastructure & support.

Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=736

Regional Outlook of Global Cervical Cancer Diagnostic Tests Market

In terms of region, the global cervical cancer diagnostic tests market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America held the largest share of the global cervical cancer diagnostic tests market in 2021, followed by Europe. North America dominated the market due to the presence of a large number of diagnostic kits and device providers, which helped cervical cancer patients in the region with easy access to screening solutions, rapid technological advancements, and assisted the baby boomer population that can afford high cost of diagnostic procedures. The high prevalence and incidence rate of cervical cancer among the population and increase in government initiatives on cancer awareness are likely to fuel the growth of the market in the next few years.

Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=736

Analysis of Key Players in Global Cervical Cancer Diagnostic Tests Market

The global cervical cancer diagnostic tests market is highly fragmented as a number of players are providing different and advanced products to gain edge over competitors. Key players operating in the global cervical cancer diagnostic tests market include F. Hoffmann-La Roche Ltd., Abbott, Quest Diagnostics Incorporated, QIAGEN, Hologic, Inc., DYSIS Medical, Inc., Femasys, Inc., Guided Therapeutics, Inc., Cooper Companies, Inc., and BD.

Each of these players has been profiled in the cervical cancer diagnostic tests market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.

More Trending Reports by Transparency Market Research –

Cervical Cancer Diagnostic Tests Market: The global cervical cancer diagnostic tests market is expected to exceed value of US$ 13.6 Bn by the end of 2031.

Central Lab Market: The global central lab market is expected to reach the value of US$ 4 Bn by the end of 2031.

In Vitro Diagnostics Market: The global in vitro diagnostics market is expected to reach the value of US$ 115.43 Bn by the end of 2028.

ASRs and RUOs Market: The U.S. ASRs and RUOs market is expected to surpass the value of US$ 5.3 Bn by the end of 2031.

Companion Diagnostics Market: The global companion diagnostics market is expected to reach the value of US$ 9.30 Bn by the end of 2028.

Respiratory Panel Testing Market: The Europe and Middle East & Africa respiratory panel testing market is expected to surpass the value of US$ 3.1 Bn by the end of 2031.

Direct-to-Consumer Laboratory Testing Market: The direct-to-consumer laboratory testing market in North America is projected to expand at a CAGR of 22.6% during the forecast period.

Pressure Ulcer Diagnostics Market: The global pressure ulcer diagnostics market was valued at US$ 880.50 Mn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Blog: https://tmrblog.com

Email: sales@transparencymarketresearch.com

Back to news